KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Return on Assets (2019 - 2025)

Historic Return on Assets for Esperion Therapeutics (ESPR) over the last 8 years, with Q3 2025 value amounting to 0.3%.

  • Esperion Therapeutics' Return on Assets fell 1800.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 0.02% for FY2024, which is 9300.0% up from last year.
  • As of Q3 2025, Esperion Therapeutics' Return on Assets stood at 0.3%, which was down 1800.0% from 0.32% recorded in Q2 2025.
  • Esperion Therapeutics' Return on Assets' 5-year high stood at 0.01% during Q4 2024, with a 5-year trough of 1.22% in Q3 2021.
  • Over the past 5 years, Esperion Therapeutics' median Return on Assets value was 0.81% (recorded in 2022), while the average stood at 0.65%.
  • In the last 5 years, Esperion Therapeutics' Return on Assets plummeted by -8700bps in 2021 and then skyrocketed by 9900bps in 2024.
  • Over the past 5 years, Esperion Therapeutics' Return on Assets (Quarter) stood at 0.9% in 2021, then rose by 6bps to 0.84% in 2022, then decreased by -19bps to 1.0% in 2023, then soared by 99bps to 0.01% in 2024, then crashed by -1956bps to 0.3% in 2025.
  • Its Return on Assets stands at 0.3% for Q3 2025, versus 0.32% for Q2 2025 and 0.31% for Q1 2025.